内部人交易雷达

美国 · SEC Form 4 · 快照日期: 2026-10-18 · 构建时间: 2026-10-18 · English

← 美国市场 · 覆盖记录

美国 · SEC FORM 4

Akari Therapeutics Plc

AKTX · Nasdaq · CIK 0001541157 · Healthcare · Biotechnology

内部人信号

当前没有活跃买入信号

0 qualifying P purchase groups
当前 180 天评分窗口

29 同一窗口内观察到的 Form 4 交易行
0 sales · 29 期权、代扣税、授予、赠与或其他交易行

最近一次合资格买入2025-08-25 · Gaslightwala Abizer · $2.7K

为什么没有活跃信号?

买入活动无
近期买入无
近期卖出无
买入信号状态未激活
评分构成

活跃窗口内没有合资格买入,因此不计算分数。缺失的输入不会被当作零分或看空信号。

Cluster未计算
买入规模未计算
角色未计算
近期性未计算
确信度未计算

为什么没有分数?

  • 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
  • 卖出及其他 Form 4 活动继续作为背景显示,不会形成负分。

卖出和其他 Form 4 活动会单独显示,不会形成负面买入信号。没有买入不会被评分为看空。

内部人活动时间轴

申报人轨道展示最近 180 天。符号形状区分交易类型;卖出仅作为背景。

AprMayJunJulAugSepOct
Farag Kameel D.Interim CFO
○○○
Patel Samir RashmikantDirector,TenPercentOwner
○○○
Bazemore Robert BDirector
○○○
Patel Sandip IDirector
○○○
Gaslightwala AbizerCEO
○○
Huh HoyoungDirector,TenPercentOwner
○○
● 买入▼ 卖出○ 其他

Showing the six most active owners; 1 additional owner(s) remain in Form 4 申报证据.

买方广度、集中度与聚集买入

合资格买入进入 180 天研究窗口后,这些模块才会启用。

信号历史

暂无已记录的活跃信号快照

Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-08-25 · Gaslightwala Abizer.

近期 Form 4 活动

0买入
0卖出
32其他 Form 4 交易行
13SEC 申报 · 365天
买入0 qualifying P line(s) · 180 days
卖出0 sale line(s) · 仅供背景
其他29 exercise / withholding / award / gift / other lines
10b5-1/计划交易Not assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

市场背景

市场背景补充近期价格表现与风险信息,不影响内部人信号。

价格表现

1M
-18.0%
3M
-23.7%
6M
+86.1%
12M
—

波动率与流动性

波动率
293.3%
Beta
—
平均每日成交额
—

估值

市值
—
P/E
—

基本面

利润率
—
ROE
-61.1%
细分行业
Biotechnology

市场数据

价格数据截至:2026-10-02 · 价格来源:OpenBB/yfinance · 来自 SEC 申报文件:ROE · 财年截止日:2025-12-31 · Status: PASS

空头余额

空头余额是券商向 FINRA 申报的外部背景数据,不影响内部人信号。

空头股数
14,529
上期报告
10,763
日均成交量
62,368
回补天数
≤ 1.0

FINRA 结算日:2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数,每月两个结算日之后约一周公布;不是占已发行股份的比例。

历史股票买入

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting owner类型证券股数平均价格估算金额来源
2025-08-25Gaslightwala Abizer买入 (P)American Depositary Shares representing Ordinary Shares3,000USD 0.90USD 2,700SEC 申报 ↗
2025-08-22Gaslightwala Abizer买入 (P)American Depositary Shares representing Ordinary Shares8,000USD 0.93USD 7,440SEC 申报 ↗
2025-08-21Gaslightwala Abizer买入 (P)American Depositary Shares representing Ordinary Shares10,000USD 0.94USD 9,400SEC 申报 ↗
2025-06-24Gaslightwala Abizer买入 (P)American Depositary Shares representing Ordinary Shares5,203USD 1.16USD 6,035SEC 申报 ↗
2025-06-23Gaslightwala Abizer买入 (P)American Depositary Shares representing Ordinary Shares943USD 1.15USD 1,084SEC 申报 ↗
2025-06-20Gaslightwala Abizer买入 (P)American Depositary Shares representing Ordinary Shares10,000USD 1.20USD 12,000SEC 申报 ↗
2025-06-17Gaslightwala Abizer买入 (P)American Depositary Shares representing Ordinary Shares15,000USD 1.20USD 18,000SEC 申报 ↗

Form 4 申报证据

32 transaction lines in the latest 365-day window; 71 in local history.

日期申报人类型证券股数平均价格估算金额来源
2026-10-14Patel Sandip I期权行权/转换 (M)American Depositary Shares representing Ordinary Shares10,052USD 0.00USD 4SEC 申报 ↗
2026-10-14Gaslightwala Abizer期权行权/转换 (M)American Depositary Shares representing Ordinary Shares27,066USD 0.00USD 11SEC 申报 ↗
2026-10-14Bazemore Robert B期权行权/转换 (M)American Depositary Shares representing Ordinary Shares3,866USD 0.00USD 2SEC 申报 ↗
展开近期 Form 4 证据 (20 grouped rows)
日期申报人类型证券股数平均价格估算金额来源
2026-10-14Patel Sandip I期权行权/转换 (M)American Depositary Shares representing Ordinary Shares10,052USD 0.00USD 4SEC 申报 ↗
2026-10-14Gaslightwala Abizer期权行权/转换 (M)American Depositary Shares representing Ordinary Shares27,066USD 0.00USD 11SEC 申报 ↗
2026-10-14Bazemore Robert B期权行权/转换 (M)American Depositary Shares representing Ordinary Shares3,866USD 0.00USD 2SEC 申报 ↗
2026-10-05Prudo-Chlebosz Raymond奖励/授予 (A)American Depositary Shares representing Ordinary Shares3,240USD 7.90USD 25,593SEC 申报 ↗
2026-10-05Patel Sandip I奖励/授予 (A)American Depositary Shares representing Ordinary Shares4,313USD 7.90USD 34,068SEC 申报 ↗
2026-10-05Patel Samir Rashmikant奖励/授予 (A)American Depositary Shares representing Ordinary Shares2,236USD 7.90USD 17,662SEC 申报 ↗
2026-10-05Huh Hoyoung奖励/授予 (A)American Depositary Shares representing Ordinary Shares6,160USD 7.90USD 48,658SEC 申报 ↗
2026-10-05Bazemore Robert B奖励/授予 (A)American Depositary Shares representing Ordinary Shares4,677USD 7.90USD 36,944SEC 申报 ↗
2026-09-29Gaslightwala Abizer奖励/授予 (A)American Depositary Shares representing Ordinary Shares6,430USD 9.72USD 62,500SEC 申报 ↗
2026-08-18Prudo-Chlebosz Raymond奖励/授予 (A)American Depositary Shares representing Ordinary Shares9,072USD 7.90USD 71,660SEC 申报 ↗
2026-08-18Patel Sandip I奖励/授予 (A)American Depositary Shares representing Ordinary Shares12,100USD 7.90USD 95,578SEC 申报 ↗
2026-08-18Patel Samir Rashmikant奖励/授予 (A)American Depositary Shares representing Ordinary Shares6,300USD 7.90USD 49,764SEC 申报 ↗
2026-08-18Huh Hoyoung奖励/授予 (A)American Depositary Shares representing Ordinary Shares17,249USD 7.90USD 136,250SEC 申报 ↗
2026-08-18Bazemore Robert B奖励/授予 (A)American Depositary Shares representing Ordinary Shares13,100USD 7.90USD 103,477SEC 申报 ↗
2026-08-17Farag Kameel D.奖励/授予 (A)American Depositary Shares representing Ordinary Shares1,728USD 7.52USD 12,995SEC 申报 ↗
2026-07-16Farag Kameel D.奖励/授予 (A)American Depositary Shares representing Ordinary Shares1,130USD 11.50USD 12,995SEC 申报 ↗
2026-07-07Patel Samir Rashmikant期权行权/转换 (M)American Depositary Shares representing Ordinary Shares22,474USD 0.43USD 9,672SEC 申报 ↗
2026-06-24Farag Kameel D.奖励/授予 (A)American Depositary Shares representing Ordinary Shares18,830USD 5.58USD 105,006SEC 申报 ↗
2025-11-01Farag Kameel D.奖励/授予 (A)American Depositary Shares representing Ordinary Shares58,619USD 0.75USD 43,964SEC 申报 ↗
2025-10-22Farag Kameel D.奖励/授予 (A)American Depositary Shares representing Ordinary Shares6,277USD 0.74USD 4,645SEC 申报 ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

快照与身份

快照日期2026-10-18
排名版本US-v1.2
数据质量PASS ELIGIBLE · —
股票代码AKTX
CIK0001541157
行业Healthcare
细分行业Biotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
交易所Nasdaq

数据覆盖

本地 Form 4 历史71 transaction lines from 2024-04-26 to 2026-10-14
7 P purchase lines · 0 S sale lines · 64 other lines
SEC 公司申报打开 SEC 申报 ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.